Rapid, Top-Quality Genetic Services

• SNP Genotyping
• High throughput of >4 billion genotypes per month
• High data quality
• Standard or customized chips
• GLP compliant


• Gene Expression
• Genome-wide human and mouse expression
• Expression studies using partially-degraded RNA samples (DASL)


• DNA Methylation
• Flexible, high throughput
• Single-site CpG resolution


• Genetic Analysis
• Fully automated pipeline
• Single marker/haplotype analysis
• Cluster computing


• Pharmacogenomics Services
• Drug rescue
• Identify niche-buster
• GCP and GLP compliant

Genizon's services rapidly provide customers high quality data at competitive prices.

High quality, high throughput genotyping, methylation and gene expression studies, and genetic data analysis are essential to all research activities at Genizon. The company has completed seven successful internal genome-wide association studies to date using these resources, resulting in the rapid discovery of multiple disease-associated genes and gene-based drug targets.

Genizon management has extensive experience in high-throughput clinical and laboratory operations in the contract research business. Genizon's CEO, Vice President of Operations, Director of Biotechnology Services and Clinical Director have more than 60 combined years of experience in a CRO environment.

For more information about Genizon's genetic services, please contact:

Diane Bouchard, Director of Biotechnology Services
514-270-3991 ext. 287
services@genizon.com